Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteresolvebio.com
Twitter@jimposada
CategoryBioTech
Phone425-576-4100
Employees
Founded2010

Offices

Kirkland, USA
5400 Carillon Point
Kirkland, WA, 98033
USA

People

Co-Founder and CEO
Board of Managers
Chief Scientific Officer
Board Observer
Managing the CMC

Funding

TOTAL $7.8M
FUNDING TOTAL $7.8M
Series A, 5/2011
New Science Ventures
Easton Capital
$2M
Series B, 11/2012
New Science Ventures
WRF Capital
Easton Capital
$5.8M
DEBT TOTAL $1.08M
Debt, 4/2012
$1.08M

Tags

Resolve Therapeutics

Resolve Therapeutics is a private biotechnology company that is dedicated to the goal of improving the lives of patients suffering from lupus. They are focused on the advancement their exciting, novel biologic compound, RSLV-125 from preclinical research through a phase IIa clinical trial. The company is based on the pioneering discoveries made by Dr. Keith Elkon and Dr. Jeff Ledbetter in their laboratories at the University of Washington School of Medicine.

Recent Milestones

Videos

Screenshots

Resolve Therapeutics screenshot
Above: Resolve Therapeutics
Uploaded: 5/20/11

Sources

  1. Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A (xconomy.com) [edit]
  2. SEC (sec.gov) [edit]
  3. Resolve Therapeutics Raises $5.8M in Series B Financing (finsmes.com) [edit]
Edit This Page
Last Edited 11/21/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy